View monthly record counts
| Month | Records |
|---|---|
| 3 | |
| 0 | |
| 4 | |
| 1 |
Data updated:
| Month | Records |
|---|---|
| 3 | |
| 0 | |
| 4 | |
| 1 |
| # | Country / Region | Records |
|---|---|---|
| 1 | India | 8 |
| # | HS Code | Description (CN) | Description (EN) | Records |
|---|---|---|---|---|
| 1 | 300490 | 其他混合或非混合产品构成的药品,已配定剂量或制成零售包装 | Other Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses, in forms or packings for retail sale | 8 |
| # | Partner Name | Country / Region | Records |
|---|---|---|---|
| 1 | QPS BIOSERVE INDIA PRIVATE LIMITED | INDIA | 4 |
| 2 | MEDREICH LIMITED | INDIA | 3 |
| 3 | VEEDA CLINICAL RESEARCH LIMITED | INDIA | 1 |
| Date | Mar 06, 2026 | Bill No. | ATC7PT0X9MNEX | ||
|---|---|---|---|---|---|
| Supplier Information | Company Name | PHARMALYTICS PTY LTD | Buyer Information | Company Name | VEEDA CLINICAL RESEARCH LIMITED |
| Address | 4 CORPORATW BOULEVARD BAYSWATER VIC 3153 SDNF AU | Address | SHIVALIK PLAZA - A 2ND FLOOR NR. I.I.M. OPP. AMA AMBAVADI | ||
| Registration No. | — | Registration No. | 0804003181 | ||
| Phone | — | Phone | 3001300 | ||
| — | MA****@VEEDACR.COM | ||||
| Product Information | HS Code | 30049099 | HS Description | 其他混合或非混合产品构成的药品,已配定剂量或制成零售包装Other Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses, in forms or packings for retail sale | |
| Product Description | FOC-REFERENCE PRODUCT(R):50/500(VILDAGLIPTIN 50MG AND MOTFORMIN HYDROCHLORIDE 500 MG FOLM-COATED TABLETS)-(60X5=300TABS)FOC-REFERENCE PRODUCT(R)50/500(VILDAGLIPTIN 50MG AND MOTFORM | Brand | — | ||
| Quantity & Price | Amount | 210.74 | Weight | — | |
| Quantity | 5 NOS | TEU | — | ||
| Shipment Information | Origin Country | AUSTRALIA | Destination Country | INDIA | |
| Port of Loading | MELBOURNE | Destination Port | AHEMDABAD AIR ACC | ||
| Loading Place | — | Transport Mode | AIR | ||
| Transaction Mode | — | Carrier | — | ||
| Vessel Name | — | Voyage | — | ||
| Container No. | — | Shipping Country | — | ||